CSIMarket
 


10x Genomics Inc   (TXG)
Other Ticker:  
 
 

TXG's Revenue Growth by Quarter and Year

10x Genomics Inc 's Revenue results by quarter and year




TXG Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 130.70 115.84 42.91
III Quarter September 153.53 113.91 105.82 71.91
II Quarter June 146.61 114.02 112.22 -61.21
I Quarter March 133.39 125.30 71.82 61.21
FY   433.53 483.93 405.70 114.82



TXG Revenue third quarter 2023 Y/Y Growth Comment
10x Genomics Inc reported Revenue improvement of 34.78% year on year in the third quarter 2023, to $ 153.53 millions, this is lower than 10x Genomics Inc 's recent average Revenue improvement of 38.25%.

Looking into third quarter 2023 results within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue growth. While 10x Genomics Inc ' s Revenue rise of 34.78% ranks overall at the positon no. 458 in the third quarter 2023.




TXG Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 12.83 % 169.96 % -
III Quarter September 34.78 % 7.65 % 47.16 % -
II Quarter June 28.58 % 1.6 % - -
I Quarter March 6.46 % 74.46 % 17.33 % -
FY   - 19.28 % 253.34 % -

Financial Statements
10x Genomics Inc 's third quarter 2023 Revenue $ 153.53 millions TXG's Income Statement
10x Genomics Inc 's third quarter 2022 Revenue $ 113.91 millions Quarterly TXG's Income Statement
New: More TXG's historic Revenue Growth >>


TXG Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 14.74 % 9.47 % -40.33 %
III Quarter September 4.72 % -0.1 % -5.7 % -
II Quarter June 9.91 % -9 % 56.25 % -
I Quarter March 2.06 % 8.17 % 67.37 % -
FY (Year on Year)   - 19.28 % 253.34 % -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #152
Overall #458

Revenue Y/Y Growth Statistics
High Average Low
170 % 38.25 % -1.67 %
(Jun 30 2021)   (Jun 30 2022)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #152
Overall #458
Revenue Y/Y Growth Statistics
High Average Low
170 % 38.25 % -1.67 %
(Jun 30 2021)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

10x Genomics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
67.39 % 12.45 % -40.33 %
(Sep 30 2020)  


TXG's III. Quarter Q/Q Revenue Comment
10x Genomics Inc achieved in the III. Quarter 2023 below company average Revenue growth of 4.72% quarter on quarter, to $ 153.53 millions.

Although the III. Quarter 2023 Revenue Q/Q growth was lower than the regular of 12.45 %, it was still encouraging news, as the current expension, outshines the -0.1% Revenue growth in the III. Quarter a year ago

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While 10x Genomics Inc 's Revenue growth quarter on quarter, overall rank is 388.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #58
Overall #388
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #58
Overall #388
Revenue Q/Q Growth Statistics
High Average Low
67.39 % 12.45 % -40.33 %
(Sep 30 2020)  


TXG's III. Quarter Q/Q Revenue Comment
10x Genomics Inc achieved in the III. Quarter 2023 below company average Revenue growth of 4.72% quarter on quarter, to $ 153.53 millions.

Although the III. Quarter 2023 TXG's Revenue sequential growth was lower than the regular , it has been still good news, as the current improvement, transcends the -0.1% Revenue rise in the III. Quarter 2022

Within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue quarter on quarter growth. While 10x Genomics Inc 's Revenue growth quarter on quarter, overall rank is 388.


10x Genomics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 564.23 $ 524.60 $ 492.01 $ 483.92 $ 469.06
Y / Y Revenue Growth (TTM) 20.29 % 13.8 % 7.15 % 19.28 % 40.96 %
Year on Year Revenue Growth Overall Ranking # 94 # 53 # 155 # 118 # 93
Seqeuential Revenue Change (TTM) 7.55 % 6.62 % 1.67 % 3.17 % 1.75 %
Seq. Revenue Growth (TTM) Overall Ranking # 859 # 871 # 1008 # 1109 # 0




Cumulative Revenue growth Comment
Although 10x Genomics Inc 's Annual Revenue growth year on year were below company's average 84.4% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 20.29% year on year, from 13.8% in Jun 30 2023. 10x Genomics Inc had also the second highest Revenue increase in Laboratory Analytical Instruments industry.

Within the Healthcare sector 25 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 53 to 94.

Revenue TTM Q/Q Growth Statistics
High Average Low
266.11 %
84.4 %
7.15 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 26
Overall # 94

Revenue TTM Y/Y Growth Statistics
High Average Low
266.11 %
84.4 %
7.15 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 101
S&P 500 # 859
Cumulative Revenue growth Comment
Although 10x Genomics Inc 's Annual Revenue growth year on year were below company's average 84.4% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 20.29% year on year, from 13.8% in Jun 30 2023. 10x Genomics Inc had also the second highest Revenue increase in Laboratory Analytical Instruments industry.

Within the Healthcare sector 25 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 53 to 94.

Revenue TTM Q/Q Growth Statistics
High Average Low
266.11 %
84.4 %
7.15 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 26
Overall # 94

Revenue TTM Y/Y Growth Statistics
High Average Low
266.11 %
84.4 %
7.15 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 101
S&P 500 # 859




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TXG's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TXG's Competitors
Revenue Growth for 10x Genomics Inc 's Suppliers
Revenue Growth for TXG's Customers

You may also want to know
TXG's Annual Growth Rates TXG's Profitability Ratios TXG's Asset Turnover Ratio TXG's Dividend Growth
TXG's Roe TXG's Valuation Ratios TXG's Financial Strength Ratios TXG's Dividend Payout Ratio
TXG's Roa TXG's Inventory Turnover Ratio TXG's Growth Rates TXG's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Molecular Templates inc 60.28%$ 60.283 millions
Sintx Technologies Inc 59.15%$ 59.155 millions
Ani Pharmaceuticals Inc57.27%$ 57.274 millions
Predictive Oncology Inc 56.87%$ 56.870 millions
Hims and Hers Health Inc 56.25%$ 56.251 millions
Sage Therapeutics Inc 56.18%$ 56.182 millions
Mannkind Corporation56.14%$ 56.140 millions
Cytomx Therapeutics Inc 55.98%$ 55.980 millions
Opgen inc 55.78%$ 55.784 millions
Impel Pharmaceuticals Inc 55.52%$ 55.516 millions
Tango Therapeutics Inc 55.09%$ 55.087 millions
Perspective Therapeutics Inc 54.53%$ 54.526 millions
Eyepoint Pharmaceuticals Inc 51.84%$ 51.838 millions
Lyra Therapeutics Inc 51.53%$ 51.532 millions
Alkermes Plc 50.95%$ 50.952 millions
Globus Medical Inc 50.95%$ 50.951 millions
Amphastar Pharmaceuticals Inc 50.30%$ 50.302 millions
Avita Medical Inc 50.08%$ 50.077 millions
Harrow Inc 49.84%$ 49.840 millions
Evolus Inc 47.55%$ 47.553 millions
Xenetic Biosciences Inc 47.54%$ 47.537 millions
Neuropace Inc 45.50%$ 45.496 millions
Sarepta Therapeutics Inc 44.10%$ 44.100 millions
Igc Pharma Inc 44.06%$ 44.059 millions
Shockwave Medical Inc 41.25%$ 41.253 millions
Aadi Bioscience Inc 40.38%$ 40.377 millions
Inspire Medical Systems inc 40.05%$ 40.052 millions
Omega Therapeutics Inc 39.66%$ 39.664 millions
Janux Therapeutics Inc 38.83%$ 38.831 millions
Viemed Healthcare Inc 38.15%$ 38.153 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com